Jin Medical International Ltd.(ZJYL)Earnings, Financials & Key Ratios

ZJYL•NASDAQ

$2.20

$344M mkt cap·93.6× P/E·Price updated May 7, 2026

SectorHealthcare IndustryMedical Instruments Sub-IndustryRehabilitation and mobility aids

AboutJin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.Show more

Revenue$24M+18.6%
EBITDA$4M+28.8%
Net Income$4M+27.7%
EPS (Diluted)0.02+18.7%
Gross Margin40.43%+18.1%
EBITDA Margin16.96%+8.7%
Operating Margin15.48%+7.0%
Net Margin15.64%+7.7%
ROE14%-4.7%
ROIC10.26%-24.6%
Debt/Equity0.41+136.9%

Technical→

ZJYL Key Insights

Jin Medical International Ltd. (ZJYL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Good 3Y average ROE of 15.7%
✓Healthy 5Y average net margin of 14.1%

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Weak momentum: RS Rating 4 (bottom 4%)
✗Trading more than 30% below 52-week high
✗Expensive at 12.1x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ZJYL Price & Volume

Jin Medical International Ltd. (ZJYL) stock price & volume — 10-year historical chart

Loading chart...

ZJYL Growth Metrics

Jin Medical International Ltd. (ZJYL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years2.9%

3 Years4.21%

TTM5.3%

Profit CAGR

10 Years-

5 Years0.16%

3 Years11.78%

TTM-10.73%

EPS CAGR

10 Years-

5 Years20.89%

3 Years33.85%

TTM-14.57%

Return on Capital

10 Years25.39%

5 Years17.22%

3 Years14.34%

Last Year13.83%

ZJYL Recent Earnings

Jin Medical International Ltd. (ZJYL) EPS & revenue vs analyst estimates — last 1 quarters

Full history →

Q1 2026Latest

Jan 23, 2026

EPS

$0.16

Revenue

$11M

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Jan 23, 2026	$0.16	$11M

Based on last 1 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
MPWRMonolithic Power Systems, Inc.Direct Competitor	77.41B	1575.96	123.60	26.43%	22.07%	17.89%	0.01
NVCRNovoCure LimitedDirect Competitor	1.92B	16.83	-13.80	8.28%	-25.66%	-50.82%	0.85
LFUSLittelfuse, Inc.Direct Competitor	11.11B	441.58	-152.27	8.92%	-1.61%	-1.57%	0.39
GKOSGlaukos CorporationDirect Competitor	7.85B	134.15	-40.90	32.33%	-34.34%	-26.46%	0.21
INVAInnoviva, Inc.Product Competitor	1.93B	22.80	6.91	18.52%	118.91%	46.47%	0.23
OSUROraSure Technologies, Inc.Product Competitor	225.25M	3.13	-3.33	-38.1%	-61.93%	-15.09%	0.04
LMATLeMaitre Vascular, Inc.Product Competitor	2.46B	107.91	42.82	13.53%	24.35%	16.19%	0.47
ATRCAtriCure, Inc.Product Competitor	1.41B	27.80	-115.83	14.88%	-0.83%	-0.95%	0.18

Compare ZJYL vs Peers

Jin Medical International Ltd. (ZJYL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MPWR

Most directly comparable listed peer for ZJYL.

Scale Benchmark

vs SYK

Larger-name benchmark to compare ZJYL against a more recognizable public peer.

Peer Set

Compare Top 5

vs MPWR, NVCR, LFUS, GKOS

ZJYL Income Statement

Jin Medical International Ltd. (ZJYL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Sep'18	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	TTM
Sales/Revenue	20.91M	20.37M	16.19M	20.76M	19.19M	19.82M	23.5M	42.95M
Revenue Growth %	-	-2.61%	-20.49%	28.22%	-7.58%	3.29%	18.57%	5.3%
Cost of Goods Sold	13.25M	12.86M	10.7M	14.4M	12.99M	13.04M	14M	27.55M
COGS % of Revenue	63.38%	63.12%	66.05%	69.36%	67.7%	65.77%	59.57%	-
Gross Profit	7.66M▲ 0%	7.51M▼ 1.9%	5.5M▼ 26.8%	6.36M▲ 15.7%	6.2M▼ 2.6%	6.78M▲ 9.5%	9.5M▲ 40.1%	15.4M▲ 0%
Gross Margin %	36.62%	36.88%	33.95%	30.64%	32.3%	34.23%	40.43%	35.85%
Gross Profit Growth %	-	-1.91%	-26.8%	15.69%	-2.56%	9.46%	40.06%	-
Operating Expenses	3.33M	3.11M	3.14M	3.73M	4.07M	3.92M	5.86M	11.12M
OpEx % of Revenue	15.94%	15.26%	19.41%	17.96%	21.2%	19.76%	24.95%	-
Selling, General & Admin	2.23M	1.98M	1.88M	2.16M	2.18M	2.37M	4.37M	7.81M
SG&A % of Revenue	10.66%	9.71%	11.62%	10.42%	11.34%	11.98%	18.58%	-
Research & Development	1.2M	1.13M	1.26M	1.57M	1.89M	1.54M	1.5M	3.07M
R&D % of Revenue	5.75%	5.55%	7.79%	7.55%	9.86%	7.78%	6.37%	-
Other Operating Expenses	0	0	0	0	0	0	0	237.57K
Operating Income	4.23M▲ 0%	4.4M▲ 4.2%	2.35M▼ 46.5%	2.63M▲ 11.8%	2.13M▼ 19.0%	2.87M▲ 34.6%	3.64M▲ 26.9%	4.28M▲ 0%
Operating Margin %	20.22%	21.62%	14.54%	12.67%	11.1%	14.47%	15.48%	9.97%
Operating Income Growth %	-	4.17%	-46.53%	11.76%	-19.04%	34.58%	26.91%	-
EBITDA	4.6M	4.75M	2.68M	2.97M	2.49M	3.09M	3.98M	4.76M
EBITDA Margin %	21.98%	23.31%	16.55%	14.32%	12.96%	15.61%	16.96%	11.08%
EBITDA Growth %	-	3.31%	-43.56%	10.94%	-16.31%	24.33%	28.83%	-11.04%
D&A (Non-Cash Add-back)	368.26K	344.04K	324.93K	341.25K	357.27K	225.9K	346.13K	478.07K
EBIT	4.23M	4.4M	2.47M	2.89M	2.74M	2.87M	3.64M	4.44M
Net Interest Income	0	0	-112.4K	-9.49K	181.6K	182.68K	466.52K	1.07M
Interest Income	25.24K	0	0	0	181.6K	182.68K	466.52K	1.28M
Interest Expense	0	22.85K	112.4K	9.49K	0	0	0	215.06K
Other Income/Expense	71.02K	-276.61K	-1.52K	248.84K	612.11K	354.68K	544.97K	1.18M
Pretax Income	4.3M▲ 0%	4.13M▼ 4.0%	2.35M▼ 43.0%	2.88M▲ 22.4%	2.74M▼ 4.8%	3.22M▲ 17.5%	4.18M▲ 29.9%	5.46M▲ 0%
Pretax Margin %	20.56%	20.26%	14.53%	13.87%	14.29%	16.25%	17.8%	12.72%
Income Tax	616.88K	479.63K	147.15K	248.64K	36.11K	343.71K	763.88K	923.1K
Effective Tax Rate %	14.35%	11.62%	6.25%	8.63%	1.32%	10.67%	18.26%	16.89%
Net Income	3.68M▲ 0%	3.65M▼ 0.9%	2.21M▼ 39.5%	2.63M▲ 19.3%	2.71M▲ 2.8%	2.88M▲ 6.3%	3.68M▲ 27.7%	4.7M▲ 0%
Net Margin %	17.61%	17.91%	13.62%	12.67%	14.1%	14.52%	15.64%	10.94%
Net Income Growth %	-	-0.93%	-39.52%	19.3%	2.84%	6.34%	27.71%	-10.73%
Net Income (Continuing)	3.68M	3.65M	2.21M	2.63M	2.71M	2.88M	3.42M	4.54M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	-262.72K	-156.23K
EPS (Diluted)	0.01▲ 0%	0.01▼ 1.1%	0.01▼ 39.6%	0.01▲ 78.2%	0.02▲ 104.1%	0.02▼ 1.0%	0.02▲ 18.7%	0.03▲ 0%
EPS Growth %	-	-	-	-	-	-1%	18.69%	-14.57%
EPS (Basic)	0.01	0.01	0.01	0.01	0.02	0.02	0.02	-
Diluted Shares Outstanding	400M	400M	400M	267.5M	135M	145.14M	156.47M	156.55M
Basic Shares Outstanding	400.01M	400.12M	400.22M	267.57M	135.02M	145.14M	156.48M	156.7M
Dividend Payout Ratio	-	-	-	-	-	-	-	-

ZJYL Balance Sheet

Jin Medical International Ltd. (ZJYL) balance sheet — assets, liabilities & shareholders' equity

Line item	Sep'18	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	TTM
Total Current Assets	15.61M	17.7M	18.16M	19.42M	18.9M	31.12M	42.82M	43.78M
Cash & Short-Term Investments	2.45M	3.34M	2.84M	5.73M	7.07M	16.7M	26.76M	30.96M
Cash Only	853.3K	1.94M	1.66M	3.67M	4.79M	6.93M	8.14M	11.13M
Short-Term Investments	1.6M	1.4M	1.18M	2.05M	2.28M	9.77M	18.62M	19.82M
Accounts Receivable	6.34M	8.63M	7.86M	5.98M	4.25M	8.5M	8.78M	5.62M
Days Sales Outstanding	110.7	154.59	177.19	105.11	80.87	156.53	136.29	60.42
Inventory	6.06M	5.74M	7.25M	7.04M	6.88M	5.86M	7.12M	6.1M
Days Inventory Outstanding	166.91	162.85	247.51	178.44	193.31	163.98	185.58	84.24
Other Current Assets	745.95K	333.06K	-83.47K	523.47K	544.9K	60K	0	1.01M
Total Non-Current Assets	3.07M	2.66M	2.66M	2.48M	2.04M	1.79M	2.98M	4.74M
Property, Plant & Equipment	2.74M	2.38M	2.31M	2.11M	1.63M	1.48M	1.72M	3.51M
Fixed Asset Turnover	7.62x	8.57x	7.02x	9.83x	11.79x	13.39x	13.69x	20.36x
Goodwill	0	0	0	0	0	0	0	0
Intangible Assets	189.34K	177.29K	180.89K	185.1K	163.21K	154.36K	1.15M	1.09M
Long-Term Investments	0	-177	-366.43K	0	-245	-152.47K	0	-152.47K
Other Non-Current Assets	140.16K	15.53K	366.43K	0	245	152.47K	0	286.92K
Total Assets	18.68M▲ 0%	20.36M▲ 9.0%	20.82M▲ 2.2%	21.9M▲ 5.2%	20.94M▼ 4.4%	32.9M▲ 57.1%	45.8M▲ 39.2%	48.52M▲ 0%
Asset Turnover	1.12x	1.00x	0.78x	0.95x	0.92x	0.60x	0.51x	1.02x
Asset Growth %	-	9.01%	2.23%	5.22%	-4.39%	57.14%	39.2%	146.9%
Total Current Liabilities	9.68M	9.66M	10.01M	7.87M	5.7M	8.92M	17.15M	20.74M
Accounts Payable	7.75M	4.76M	5.43M	5.35M	4.11M	3.39M	3.01M	3.06M
Days Payables Outstanding	213.31	135.18	185.45	135.61	115.57	94.94	78.54	41.75
Short-Term Debt	712.53K	2.87M	2.65M	0	0	4.11M	11.32M	15.73M
Deferred Revenue (Current)	0	1.02M	975.65K	1.68M	830.3K	829.22K	797.08K	2.3M
Other Current Liabilities	669.25K	1.56M	306.28K	0	366.16K	272.55K	0	1.34M
Current Ratio	1.61x	1.83x	1.81x	2.47x	3.31x	3.49x	2.50x	2.50x
Quick Ratio	0.99x	1.24x	1.09x	1.57x	2.11x	2.83x	2.08x	2.08x
Cash Conversion Cycle	64.3	182.26	239.25	147.95	158.62	225.57	243.33	102.92
Total Non-Current Liabilities	0	0	0	0	0	0	96.17K	30.09K
Long-Term Debt	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	96.17K	305.96K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0
Total Liabilities	9.68M	9.66M	10.01M	7.87M	5.7M	8.92M	17.25M	20.77M
Total Debt	712.53K	2.87M	2.65M	0	0	4.11M	11.6M	15.92M
Net Debt	-140.77K	929.86K	983.72K	-3.67M	-4.79M	-2.82M	3.47M	4.78M
Debt / Equity	0.08x	0.27x	0.25x	-	-	0.17x	0.41x	0.41x
Debt / EBITDA	0.16x	0.60x	0.99x	-	-	1.33x	2.91x	3.34x
Net Debt / EBITDA	-0.03x	0.20x	0.37x	-1.24x	-1.93x	-0.91x	0.87x	0.87x
Interest Coverage	-	192.76x	20.95x	277.23x	-	-	-	20.63x
Total Equity	9M▲ 0%	10.71M▲ 18.9%	10.8M▲ 0.9%	14.03M▲ 29.9%	15.24M▲ 8.6%	23.98M▲ 57.4%	28.55M▲ 19.1%	27.76M▲ 0%
Equity Growth %	-	18.93%	0.91%	29.87%	8.6%	57.39%	19.07%	93.66%
Book Value per Share	0.02	0.03	0.03	0.05	0.11	0.17	0.18	0.18
Total Shareholders' Equity	9M	10.71M	10.8M	14.03M	15.24M	23.98M	28.82M	27.91M
Common Stock	20K	20K	6.75K	6.75K	6.75K	7.8K	7.83K	7.83K
Retained Earnings	4.87M	7.54M	9.6M	11.89M	14.41M	16.93M	20.02M	22.53M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	461.44K	1.02M	1.11M	2.06M	740.29K	606.52K	2.04M	-1.37M
Minority Interest	0	0	0	0	0	0	-262.72K	-156.23K

ZJYL Cash Flow Statement

Jin Medical International Ltd. (ZJYL) cash flow — operating, investing & free cash flow history

Line item	Sep'18	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	TTM
Cash from Operations	-2.39M	-1.33M	2.5M	5.84M	1.58M	3.11M	-1.21M	-1.21M
Operating CF Margin %	-11.45%	-6.51%	15.46%	28.14%	8.24%	15.67%	-5.14%	-
Operating CF Growth %	-	44.64%	288.85%	133.43%	-72.95%	96.53%	-138.86%	9526.14%
Net Income	3.68M	3.65M	2.21M	2.63M	2.71M	2.88M	3.42M	4.7M
Depreciation & Amortization	368.26K	344.04K	329.91K	346.61K	362.6K	225.9K	346.13K	658.43K
Stock-Based Compensation	0	0	0	0	0	0	0	0
Deferred Taxes	0	-30.36K	-77.92K	-1.66K	-86.02K	89.6K	36.33K	21.04K
Other Non-Cash Items	569.69K	5.47M	80.05K	-91.31K	28.94K	113.48K	-89.93K	2.21M
Working Capital Changes	-7.01M	-5.32M	-34.86K	2.96M	-1.43M	-200.81K	-4.92M	-2.93M
Change in Receivables	-3.97M	-2.21M	1.12M	3.08M	333.66K	-376.08K	-3.91M	-1.65M
Change in Inventory	-1.77M	248.34K	-1.37M	458.61K	-504.39K	1.56M	80.31K	1.73M
Change in Payables	0	-2.79M	425.9K	-369.08K	-810.34K	-646.89K	-499.57K	-995.47K
Cash from Investing	1.96M	126.94K	-1.96M	-1.07M	-120.9K	-7.73M	-9.51M	-18.55M
Capital Expenditures	-187.68K	-73.33K	-142.32K	-42.88K	-40.17K	-113.94K	-144.95K	-2.3M
CapEx % of Revenue	0.9%	0.36%	0.88%	0.21%	0.21%	0.57%	0.62%	-
Acquisitions	0	0	207	0	0	0	0	-489.96K
Investments	-	-	-	-	-	-	-	-
Other Investing	2.15M	54.85K	-2.1M	-215.03K	364.43K	10.14K	-978.93K	-10.43M
Cash from Financing	-3.19M	2.36M	-343.91K	-2.87M	121.86K	6.91M	11.65M	20.27M
Debt Issued (Net)	0	0	-355.32K	-2.77M	0	4.25M	6.87M	12.43M
Equity Issued (Net)	0	0	0	0	0	1000K	312K	336.64K
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0
Other Financing	-3.19M	2.36M	11.42K	-103.88K	121.86K	-5.34M	4.48M	7.5M
Net Change in Cash	-3.59M▲ 0%	1.09M▲ 130.4%	-278.44K▼ 125.6%	2.01M▲ 821.4%	1.12M▼ 44.2%	2.14M▲ 90.7%	1.21M▼ 43.5%	-6.66M▲ 0%
Free Cash Flow	-2.58M▲ 0%	-1.4M▲ 45.8%	2.36M▲ 268.8%	5.8M▲ 145.7%	1.54M▼ 73.4%	2.99M▲ 94.3%	-2.33M▼ 177.9%	-581.37K▲ 0%
FCF Margin %	-12.35%	-6.87%	14.58%	27.93%	8.03%	15.1%	-9.92%	-1.35%
FCF Growth %	-	45.82%	268.78%	145.69%	-73.44%	94.25%	-177.91%	-109.28%
FCF per Share	-0.01	-0.00	0.01	0.02	0.01	0.02	-0.01	-0.01
FCF Conversion (FCF/Net Income)	-0.65x	-0.36x	1.13x	2.22x	0.58x	1.08x	-0.33x	-0.12x
Interest Paid	0	0	136.55K	68.78K	0	5.32K	239.37K	448.36K
Taxes Paid	0	0	522.11K	302.25K	47.44K	142.73K	205.37K	0

ZJYL Key Ratios

Jin Medical International Ltd. (ZJYL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2019	2020	2021	2022	2023	2024	TTM
Return on Equity (ROE)	37.02%	20.51%	21.2%	18.5%	14.68%	14%	16.93%
Return on Invested Capital (ROIC)	32.23%	15.08%	17.83%	15.36%	13.61%	10.26%	10.26%
Gross Margin	36.88%	33.95%	30.64%	32.3%	34.23%	40.43%	35.85%
Net Margin	17.91%	13.62%	12.67%	14.1%	14.52%	15.64%	10.94%
Debt / Equity	0.27x	0.25x	-	-	0.17x	0.41x	0.41x
Interest Coverage	192.76x	20.95x	277.23x	-	-	-	20.63x
FCF Conversion	-0.36x	1.13x	2.22x	0.58x	1.08x	-0.33x	-0.12x
Revenue Growth	-2.61%	-20.49%	28.22%	-7.58%	3.29%	18.57%	5.3%

ZJYL Frequently Asked Questions

Jin Medical International Ltd. (ZJYL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Jin Medical International Ltd. (ZJYL) reported $43.0M in revenue for fiscal year 2024. This represents a 105% increase from $20.9M in 2018.

Jin Medical International Ltd. (ZJYL) grew revenue by 18.6% over the past year. This is strong growth.

Yes, Jin Medical International Ltd. (ZJYL) is profitable, generating $4.7M in net income for fiscal year 2024 (15.6% net margin).

Dividend & Returns

Jin Medical International Ltd. (ZJYL) has a return on equity (ROE) of 14.0%. This is reasonable for most industries.

Jin Medical International Ltd. (ZJYL) had negative free cash flow of $0.6M in fiscal year 2024, likely due to heavy capital investments.

Explore More ZJYL

Jin Medical International Ltd. (ZJYL) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Jin Medical International Ltd.(ZJYL)Earnings, Financials & Key Ratios

ZJYL Key Insights

✓Strengths

✗Weaknesses

ZJYL Price & Volume

ZJYL Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

ZJYL Recent Earnings

ZJYL Peer Comparison

Compare ZJYL vs Peers

vs MPWR

vs SYK

Compare Top 5

ZJYL Income Statement

ZJYL Balance Sheet

ZJYL Cash Flow Statement

ZJYL Key Ratios

ZJYL Frequently Asked Questions

Explore More ZJYL

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation